CANTABIO PHARMACEUTICALS
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focusing on commercializing novel therapies and the intellectual property generated from their research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
CANTABIO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.cantabio.com
Total Employee:
11+
Status:
Active
Contact:
(408) 501-8893
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Microsoft Exchange Online Amazon
Similar Organizations
Boston Pharmaceuticals
Boston Pharmaceuticals Provides Healthcare Services.
Ergon Pharmaceuticals
Ergon Pharmaceuticals is a small translational preclinical-stage biotechnology firm
Splash Pharmaceuticals
Splash Pharmaceuticals is a clinical stage oncology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.cantabio.com Semrush global rank: 6.24 M Semrush visits lastest month: 1.23 K
- Host name: server-3-162-112-81.iad61.r.cloudfront.net
- IP address: 3.162.112.81
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cantabio Pharmaceuticals"
Cantabio Pharmaceuticals - Crunchbase Company Profile & Funding
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focusing on commercializing novel therapies and the intellectual property generated from their research …See details»
About Cantabio Pharmaceuticals
Contact :: Cantabio Pharmaceuticals Inc.
Cantabio Pharmaceuticals Inc. 2225 East Bayshore Road Palo Alto, CA 94303. Main Office: 844-200-2826 [email protected]. Investor Relations (844) 200-CTBOSee details»
Cantabio Pharmaceuticals, Inc. | LinkedIn
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company focussing on commercializing novel therapies and the intellectual property generated from our research and …See details»
Press Release Distribution and Management - GlobeNewswire
SAN FRANCISCO and WEST LAFAYETTE, Ind., July 11, 2016 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals, Inc. (OTCQB:CTBO) today announced the signing of an …See details»
Cantabio Pharmaceuticals - Contacts, Employees, Board Members, …
Cantabio Pharmaceuticals has 1 current employee profile, Chief Executive Officer, Chief Scientific Officer and Founder Gergely Tóth. Contacts Edit Contacts SectionSee details»
Cantabio Pharmaceuticals - Overview, News & Similar companies ...
Oct 20, 2019 Cantabio Pharmaceuticals and LIH collaborate on the therapeutic targeting of DJ-1 (Luxembourg Institute of Health) Cantabio Pharmaceuticals, Inc., a preclinical stage …See details»
Cantabio Pharmaceuticals Company Profile - Office Locations ...
Jul 17, 2024 Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and …See details»
Cantabio Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Cantabio Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 5 literature, Disease Domain:Endocrinology and Metabolic Disease, …See details»
Cantabio Pharmaceuticals - Funding, Financials, Valuation
Aug 17, 2023 Cantabio Pharmaceuticals is funded by Michael J. Fox Foundation. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 1. ... Show . How much …See details»
Scientific Advisors :: Cantabio Pharmaceuticals Inc.
Nov 13, 2019 Cantabio Announces Publication of Novel Study Demonstrating the Importance of the DJ-1 Protein in the Onset and Pathology of Alzheimer's and Parkinson's disease About …See details»
Cantabio Pharmaceuticals Awarded Grant From The Michael J. Fox ...
Jan 5, 2022 Grant enables the further development of Cantabio's novel small-molecule tau protein aggregation inhibitors, which have high therapeutic potential in both disease-modifying …See details»
Cantabio Pharmaceuticals, Inc. (Cantabio Pharmaceuticals, Inc.)
了解Cantabio Pharmaceuticals, Inc. (Cantabio Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻和5篇文献，疾病领域:内分泌与代谢疾病，神经系统疾病，技 …See details»
Cantab Biopharmaceuticals - Crunchbase Company Profile
Cantab Biopharmaceuticals Ltd is a drug development company focused on the development of "biosuperior" products. Based on Cambridge Science Park, Cantab is at the heart of the …See details»
Overview :: Cantabio Pharmaceuticals Inc.
Cantabio’s ability to generate a pipeline of high quality therapeutic candidates stems from its integration of key elements and novel discovery techniques, combined with years of …See details»
Cantabio Pharmaceuticals, Inc. Stock - MarketScreener.com
Jul 19, 2017 Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company. The Company is focused on commercializing therapies and the intellectual property generated …See details»
Cantabio Pharmaceuticals Inc (CTBO) Stock Price and News
Real-time Price Updates for Cantabio Pharmaceuticals Inc (CTBO), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
Pipeline :: Cantabio Pharmaceuticals Inc.
Cantabio is constantly searching for complementary technologies and R&D partnerships to complement the companies’ core scientific and technological intellectual property and …See details»
Cantabio in the News :: Cantabio Pharmaceuticals Inc.
Cantabio was highlighted in this year’s World Economic Forum report titled “Top 10 Emerging Technologies 2019” as one of the top 10 emerging world-changing technologies for 2019. The …See details»